Literature DB >> 12445785

Asymmetric binding of histone H1 stabilizes MMTV nucleosomes and the interaction of progesterone receptor with the exposed HRE.

Guillermo P Vicent1, María J Meliá, Miguel Beato.   

Abstract

Packaging of mouse mammary tumor virus (MMTV) promoter sequences in nucleosomes modulates access of DNA binding proteins and influences the interaction among DNA bound transcription factors. Here we analyze the binding of histone H1 to MMTV mononucleosomes assembled with recombinant histones and study its influence on nucleosome structure and stability as well as on progesterone receptor (PR) binding to the hormone responsive elements (HREs). The MMTV nucleosomes can be separated into three main populations, two of which exhibited precise translational positioning. Histone H1 bound preferentially to the 5' distal nucleosomal DNA protecting additional 27-28 nt from digestion by micrococcal nuclease. Binding of histone H1 was unaffected by prior crosslinking of protein and DNA in nucleosomes with formaldehyde. Neither the translational nor the rotational nucleosome positioning was altered by histone H1 binding, but the nucleosomes were stabilized as judged by the kinetics of nuclease cleavage. Unexpectedly, binding of recombinant PR to the exposed distal HRE-I in nucleosomes was enhanced in the presence of histone H1, as demonstrated by band shift and footprinting experiments. This enhanced PR affinity may contribute to the reported positive effect of histone H1 on the hormonal activation of MMTV reporter genes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12445785     DOI: 10.1016/s0022-2836(02)01101-4

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  8 in total

Review 1.  Minireview: role of kinases and chromatin remodeling in progesterone signaling to chromatin.

Authors:  Guillermo P Vicent; A Silvina Nacht; Roser Zaurín; Cecilia Ballaré; Jaime Clausell; Miguel Beato
Journal:  Mol Endocrinol       Date:  2010-05-19

2.  Nuclear factor 1 synergizes with progesterone receptor on the mouse mammary tumor virus promoter wrapped around a histone H3/H4 tetramer by facilitating access to the central hormone-responsive elements.

Authors:  Guillermo Pablo Vicent; Roser Zaurin; A Silvina Nacht; Jofre Font-Mateu; Francois Le Dily; Miguel Beato
Journal:  J Biol Chem       Date:  2009-11-24       Impact factor: 5.157

3.  Histone H1 enhances synergistic activation of the MMTV promoter in chromatin.

Authors:  Ronald Koop; Luciano Di Croce; Miguel Beato
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

4.  Transcriptionally competent chromatin assembled with exogenous histones in a yeast whole cell extract.

Authors:  Antonio Rodríguez-Campos; Ronald Koop; Susanna Faraudo; Miguel Beato
Journal:  Nucleic Acids Res       Date:  2004-07-28       Impact factor: 16.971

5.  Network of dynamic interactions between histone H1 and high-mobility-group proteins in chromatin.

Authors:  Frédéric Catez; Huan Yang; Kevin J Tracey; Raymond Reeves; Tom Misteli; Michael Bustin
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

Review 6.  Erk signaling and chromatin remodeling in MMTV promoter activation by progestins.

Authors:  Guillermo P Vicent; Roser Zaurin; Cecilia Ballaré; A Silvina Nacht; Miguel Beato
Journal:  Nucl Recept Signal       Date:  2009-10-02

7.  Progesterone receptor induces bcl-x expression through intragenic binding sites favoring RNA polymerase II elongation.

Authors:  Paola Y Bertucci; A Silvina Nacht; Mariano Alló; Luciana Rocha-Viegas; Cecilia Ballaré; Daniel Soronellas; Giancarlo Castellano; Roser Zaurin; Alberto R Kornblihtt; Miguel Beato; Guillermo P Vicent; Adali Pecci
Journal:  Nucleic Acids Res       Date:  2013-05-02       Impact factor: 16.971

8.  Depletion of human histone H1 variants uncovers specific roles in gene expression and cell growth.

Authors:  Mónica Sancho; Erika Diani; Miguel Beato; Albert Jordan
Journal:  PLoS Genet       Date:  2008-10-17       Impact factor: 5.917

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.